Allison Naleway, PhD, is an epidemiologist whose research focuses on the evaluation of vaccine safety and effectiveness and the surveillance of vaccine-preventable and other infectious diseases. Dr. Naleway is the site Principal Investigator for the Vaccine Safety Datalink, a national project funded by the Centers for Disease Control and Prevention (CDC) that links automated medical records data from several integrated health care delivery organizations to monitor vaccine safety. She leads the VSD pregnancy working group.
She has collaborated with the CDC on studies to assess the effectiveness of influenza vaccination during pregnancy, influenza vaccine choice and effectiveness in health care workers, and the early effect of human papillomavirus vaccination on HPV-related outcomes.
Dr. Naleway received her master’s and doctoral degrees in epidemiology from The University of Iowa’s College of Public Health. She completed a postdoctoral fellowship in epidemiology at the Marshfield Clinic Research Foundation. Dr. Naleway has adjunct faculty appointments with Oregon Health & Science University's Department of Public Health and Preventive Medicine as well as The University of Iowa College of Public Health’s Department of Epidemiology.
- Henninger ML, Irving SA, Thompson M, Avalos LA, Ball SW, Shifflett P, Naleway AL for the Pregnancy and Influenza Project (PIP) Working Group. Factors associated with seasonal influenza vaccination in pregnant women. J Womens Health 2015; 24:394-402. Epub 2015 Apr 15.
- Naleway AL, Weinmann S, Krishnarajah S, Arondekar B, Fernandez J, Swamy G, Myers E. Pregnancy after treatment for cervical cancer precursor lesions in a retrospective matched cohort. PLOS One 2015; 10:e0117525.
- Naleway AL, Weinmann S, Crane B, Gee J, Markowitz LE, Dunne EF. Evaluation of a surveillance case definition for anogenital warts, Kaiser Permanente Northwest. Sex Transm Dis 2014; 41:496-500.
- Naleway AL, Irving SA, Henninger ML, Li D, Shifflett P, Ball S, Williams J, Cragan J, Gee J, Thompson MG. Safety of influenza vaccination during pregnancy: a review of subsequent maternal obstetric events and findings from two recent cohort studies. Vaccine 2014; 32:3122-7. Epub 2014 Apr 14.
- Naleway AL, Henkle EM, Ball S, Bozeman S, Gaglani MJ, Kennedy ED, Thompson MG. Barriers and facilitators to influenza vaccination and vaccine coverage in a cohort of healthcare personnel. Am J Infect Control 2014; 42:371-5.
- Naleway AL, Kurosky S, Henninger ML, Gold R, Nordin JD, Kharbanda EO, Irving S, Cheetham TC, Nakasato C, Glanz J, Hambidge SJ, Davis RL, Klein NP, McCarthy NL, Weintraub S. Vaccinations given during pregnancy, 2002-2009: A descriptive study. Am J Prev Med 2014; 46:150-7.
- Naleway AL, Gold R, Kurosky S, Riedlinger K, Henninger ML, Nordin JD, Kharbanda EO, Irving S, Cheetham TC, McCarthy NL. Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink. Vaccine 2013; 31:2898-903. Epub 2013 Apr 29.
- Naleway AL, Gold R, Drew L, Riedlinger K, Henninger ML, Gee J. Reported adverse events in young women following quadrivalent human papillomavirus vaccination. J Womens Health 2012; 21:425-35. Epub 2012 Jan 9.
- Gee J, Naleway A, Shui I, Baggs J, Yin R, Li R, Kulldorff M, Lewis E, Fireman B, Daley MF, Klein NP, Weintraub E. Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink. Vaccine 2011; 29:8279-84. Epub 2011 Sep 9.
- Naleway AL, Smith WJ, Mullooly JP. Delivering influenza vaccine to pregnant women. Epidemiol Rev 2006; 28:47-53. Epub 2006 May 26.